Left Menu
Development News Edition

Australia not worried about vaccine trial pause, cases rise in hot spot

Australia is not worried about AstraZeneca Plc's decision to put on hold its COVID-19 vaccine trial, its deputy chief medical officer said on Wednesday, as daily cases nudged higher in the country's coronavirus hot spot.

Reuters | Updated: 09-09-2020 06:27 IST | Created: 09-09-2020 06:27 IST
Australia not worried about vaccine trial pause, cases rise in hot spot

Australia is not worried about AstraZeneca Plc's decision to put on hold its COVID-19 vaccine trial, its deputy chief medical officer said on Wednesday, as daily cases nudged higher in the country's coronavirus hot spot. AstraZeneca on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.

The nature of the case and when it happened were not detailed, although the participant is expected to recover, according to Stat News, which first reported the news. "With the information that I have got at the moment, I am not worried about it," Australia's Deputy Chief Medical Officer Nick Coatsworth told Sky News, adding the hold on trials does not mean the vaccine "is off the table".

"In some respects, this is a very positive thing because it shows that despite the accelerated vaccine development, safety is the priority of the clinical trialists and investigators." Coatsworth said Australia like many other governments has invested in several coronavirus vaccine candidates, "knowing not all of them will get through".

AstraZeneca's decision to place the trial on hold comes after a pledge from nine leading U.S. and European vaccine developers on Tuesday to uphold scientific safety and efficacy standards for their vaccines despite the urgency to contain the pandemic. Australia on Monday said it would get the first doses of AstraZeneca's vaccine in January 2021 if trials proved successful after reaching a preliminary deal in August.

It had also signed an agreement on a COVID-19 vaccine being developed by the University of Queensland. Both these vaccines will be manufactured locally by CSL Ltd. Australia's coronavirus hot spot of Victoria on Wednesday, meanwhile, reported its biggest rise in daily cases in three days as the state boosted its contact tracing programme to ease the spread of the virus.

Victoria, which is at the centre of Australia's second wave of coronavirus outbreak, now accounts for about 75% of Australia's 26,450 COVID-19 cases and 90% of its 781 deaths. The state reported 76 new cases and 11 deaths from the virus in the last 24 hours.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Growth of e-commerce in grocery channels irreversible; will co-exist with general trade: HUL CMD

Growth of e-commerce in the grocery segment is irreversible but kirana stores and modern trade channels would also remain relevant, Hindustan Unilever CMD Sanjiv Mehta said on Wednesday. Mehta also said rural sales are growing faster than t...

Cush Jumbo, James Nesbitt to star in Netflix adaptation of 'Stay Close'

The Good Fight star Cush Jumbo and James Nesbitt of The Missing fame have boarded the cast of the series adaptation of the bestselling novel Stay Close at Netflix. Richard Armitage, known for The Stranger, and Bancroft actor Sarah Parish ar...

India trials of Russian Sputnik-V vaccine may end as early as March - Dr Reddy's

Drugmaker Dr. Reddys Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russias coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021. Chief Executive Offi...

Dropping 1995 case against SP as precondition to SP-BSP alliance was 'big mistake': Mayawati

Former Chief Minister of Uttar Pradesh and Bahujan Samaj Party BSP chief Mayawati on Thursday said that dropping the 1995 case against Samajwadi Party SP as a precondition to SP-BSP alliance was a big mistake. I want to disclose that when ...

Give Feedback